logo
Joburg woman finishes epic N1 walk to Cape Town for husband's rare disease 10 days early

Joburg woman finishes epic N1 walk to Cape Town for husband's rare disease 10 days early

News2411-06-2025

Nicole Liedemann-Telukram completed her 1 400km walk from Johannesburg to Cape Town 10 days ahead of schedule, raising awareness and funds for her husband Shaun's rare condition, Dercum's disease.
Supported throughout the journey by her best friend, Paballo, in a safety vehicle and her trusty boerboel, Zaza, Nicole described the journey as physically and emotionally transformative, highlighting the mental endurance required and the generosity of South Africans along the way.
The campaign has raised R15 000 so far, and Nicole remains committed to fighting for rare disease research and funding, saying, 'This is just the start.'
Nicole Liedemann-Telukram has completed her 1 400km walk from Johannesburg to Cape Town, 10 days ahead of schedule.
Just over a month ago, Nicole decided to embark on a journey along the N1 to raise awareness and funds for her husband Shaun Telukram's rare disease, called Dercum's disease.
She documented the trip on TikTok and directed followers to her fundraising platforms.
- See Nicole's BackaBuddy page
More than a month after starting the walk, she arrived in sunny Cape Town to take a photo at the famous V&A Waterfront sign.
Her journey was not without difficulties. A pulled hamstring just after Lainsburg and the physical demands of walking the Huguenot Tunnel tested her endurance. One of the most physically taxing parts of her journey was near Colesberg when she battled blisters and the flu.
'My body felt like it was giving up on me,' Nicole told News24 in Cape Town.
'When you are walking, it's only yourself and your thoughts. I don't walk with earphones in; it's just myself and the road. Your mind gets to you, where you feel self-doubt, but you have to pull yourself towards yourself and remind yourself the reason why you are doing it.'
While the first leg of the journey began with excitement, the second half became more difficult.
'It's not just about Dercum's, it's about so many things,' she said.
Nicole expressed deep gratitude for the support of her best friend, Paballo, who accompanied her by car for the entire journey for safety and her trusty boerboel, Zaza.
'Paddy, my sister, my best friend, motivator, Swiss Army knife, master of all... I could not be more grateful. I don't think there are enough words to describe how blessed I was to have had her on this journey. Yes, I was walking, but I could not have done it without her.'
Supplied/Neo Paballo-Mahao
Because the pair remained vigilant, they generally felt safe on their journey. One hair-raising moment came in Paarl, where they heard that a body had been found nearby. This did not deter them: 'There was a task that needed to be completed, a personal task, a mental task, an emotional task, a physical task. And yes, we completed it. I'm still in awe.'
Kind South Africans and the plight goes on
Nicole arrived in Cape Town last week with a deep sense of fulfilment.
'I sat there in silence with a big smile on my face. We did it. I actually did it. When you do something out of your comfort zone and succeed, it takes you back a little. I was filled with emotion, excitement and fulfilment.'
READ | Joburg woman halfway through N1 walk to Cape Town, beating blisters, blessed by strangers
Messages of pride and congratulations from family and friends continue to pour in.
'I hope I reached the people I needed to. The people we spoke to along the way made it all worthwhile. Mentally, I'm okay – I haven't processed everything yet, but I'm still extremely positive and optimistic.'
The campaign has so far raised around R15 000 and Nicole is determined to continue her fundraising efforts and search for sponsors, as they aim to reach R200 000. Dr Karen Herbst, one of the leading Dercum's researchers in the world, based in the US, also got in touch to amplify Nicole's efforts.
'We did not raise too much, but my plight has not stopped. I'm still continuing to raise awareness and funds. We didn't raise much at all, but it doesn't take away from the reason why I did this and why I am still going to continue to fight for a rare disease and for my husband.'
Rare disease research is underfunded. We need chemical pathologists to do the work, but we also need the funding. My mission is not complete yet.
Reflecting on the experience, Nicole said the journey was unforgettable.
'South Africa is a beautiful place. People in small towns are kind and generous. The trucking community became our cocoon of safety. We stayed at truck stops. There are so many people I want to thank. There are a lot of amazing people in this country.'
'This is just the start.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bay Area family shares frustrations after FDA rejects drug for ultra-rare Barth Syndrome
Bay Area family shares frustrations after FDA rejects drug for ultra-rare Barth Syndrome

CBS News

time12 hours ago

  • CBS News

Bay Area family shares frustrations after FDA rejects drug for ultra-rare Barth Syndrome

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is frustrated by the delay of approved treatments in the rare disease community. Approximately 150 people live with Barth Syndrome nationwide, an ultra-rare genetic disorder that affects only males and impacts muscle and heart muscle health. "He has a severe heart failure, and was admitted to the hospital where he was on intravenous medications to help his heart pump," Megan Branagh, whose son Henry has Barth Syndrome, told CBS News Bay Area. Megan's son was diagnosed with the disease when he was three months old. "There's no treatment or cure for it at all, just simply symptom management," she said. There are currently no FDA-approved therapies for the disease, but Stealth BioTherapeutics has been working for years to get a target drug approved. "Extremely long and delayed," Megan said. "We were supposed to get an answer in January, and FDA asked for a three-month extension based on some data they had requested." The drug, elamipretide, targets cardiolipins, a molecule in the mitochondria that is a key source for the gene defect. It's the only drug for Barth Syndrome clinical trials. After several delays, however, the FDA announced it will not be approving the drug application. Megan believes federal budget cuts could be one of the reasons. "There was only one person left remaining at the FDA who had a hand on our case for this final part of it," she said. "We've heard from the current administration the desire to make medication available for the rare disease community, and the support of the rare disease community. And this case defies everything that has been publicly stated over the last few months." The FDA instead recommended that more data be included in the company's resubmission of the drug application. While the company said they are optimistic for a new path forward with the agency, families like the Branaghs are anxiously waiting for the approval. "Sickening to know that there's something out there that could make a difference that might never be available for Henry or anyone else," she said. Her son is 13 years old and has endured many challenges, taking at least eight pills a day and making frequent trips to the doctor's office. "I do it and I just get it over with," Henry Branagh told CBS News Bay Area. "And I wait six more months, and they usually put a heart monitor for two days and I take it off." He shared that he enjoys playing sports, including baseball, soccer, skiing, and swimming. "I love playing with my friends," Henry said. He added that he does take more frequent breaks to maintain his heart health, and hopes there will be more treatment options for him soon. "It'd be really nice for me to have it too, because my wish is to like live one day be normal without having Barth Syndrome," Henry said. "Mainly when I'm in sports, and I'm running around, and I get tired and other kids are running way faster and have way better stamina." Dr. Hitenda Patel, the Branagh's family cardiologist, told CBS News Bay Area that he doesn't see the application rejection as a denial. "I think the FDA wants a little more data on its efficacy," Patel, who is also the pediatric cardiology director at UCSF Benioff Children's Hospital in Oakland, said. "There are a lot more designer drugs being developed. And designer drugs specifically, are often for rare diseases. And if you only have, let's say, at the most 500 patients in the world, it's very hard to get approval based on the current mandates for the FDA," he added. Patel said FDA approvals in the pediatric rare disease community are an even bigger hill to climb. "It seems like it's a delaying tactic, but I think you have to respect the FDA and its process because it's what has allowed to develop many things," he said. "And ultimately, they are in charge of the safety of the American people." He said that with work from those like the Branagh's do make an impact. "With advocacy such as the Barth Syndrome and what the Branaghs are doing, FDA has realized that there is a huge difference between approval process that is needed for the pediatric and rare disease market as opposed to something that is more common," Patel said. "Because the FDA has its mandates and you have to go through the trial process, it takes a long, long, long time." Patel said he remains optimistic for the community that often gets overlooked. And so, the fight continues for the Branaghs. "Super proud. He inspires us to live our best every moment and take nothing for granted," Henry's mother said. "I think the worst thing to watch as a parent to know that your kid has something that you can't do anything about." She adds that she will continue to fight for his health, no matter how long it takes. "My parents help me out a lot, they just always push me and encourage me to keep on going," Henry said. CBS News Bay Area reached out to Stealth BioTherapeutics, and a spokesperson said that while there is no public timeline yet for next steps, they are working closely with the FDA urgently to reach approval. Meanwhile, the Branaghs are preparing for their next fundraising campaign that will take place at the JBL Ranch on September 27. "Our family started something called Happy Heart Week, that is an awareness and fundraising campaign all around Barth Syndrome. 13 years now, and all the funds go directly to the foundation to support everything that they're doing," she said.

Mapulaneng hospital project clinches top industry award for GIC
Mapulaneng hospital project clinches top industry award for GIC

News24

timea day ago

  • News24

Mapulaneng hospital project clinches top industry award for GIC

Where the residents of Bushbuckridge in Mpumalanga once faced a long and gruelling journey to access professional healthcare services, there is now a brand-new, state-of-the-art hospital on their doorstep. Closing out the landmark New Mapulaneng Hospital project in style, its outstanding work has earned Gap Infrastructure Corporation the coveted Contractor of the Year title at the Big 5 Construct South Africa Impact Awards. Big 5 Construct South Africa is the country's largest event for the construction industry, and its Impact Awards receive dozens of entries each year. The announcement was made during its award ceremony at Johannesburg's Gallagher Convention Centre on Friday, 20 June, marking a fitting tribute to GIC's five-year journey in bringing the Phase 3B hospital development to fruition. 'Receiving this award is an immense honour for GIC, serving as important validation for our vision of changing lives through sustainable infrastructure,' says GIC Chief Executive Officer Roelof van den Berg. 'The New Mapulaneng Hospital exemplifies the best of our approach as an organisation. From the very start of the project, our emphasis was building a hospital while simultaneously building better futures for communities through creating jobs, transferring skills, and helping to construct world-class healthcare facilities. Now that the project has closed, this hospital will continue to deliver life-saving healthcare to residents and families, and we're grateful to have played a role in its launch.' The Phase 3B development was crucial to the hospital's long-term success, involving the construction of emergency medical services facilities, tuberculosis wards, surgical units, and mental health facilities. 'Despite the logistical challenges of building large-scale infrastructure in such a remote location, we successfully hit each milestone set and we're incredibly proud of the result, as well as of our team's complete professionalism and commitment throughout the project.' Setting industry benchmarks Evaluated by international peers and industry experts, the judges particularly noted GIC's comprehensive approach to project delivery, in addition to its exemplary safety track record, community development initiatives, and emphasis on sustainability at the New Mapulaneng Hospital. The project commenced in June 2020 and has achieved several remarkable safety milestones, including 338,759 lost-time injury-free hours as of May 2025, and a Lost Time Injury Frequency Rate (LTIFR) of 0.29. This means that there was less than one lost-time injury for every million hours worked. GIC also maintained an impressive compliance rating throughout, with a 99% compliance rating in its latest May 2025 occupational health and safety audit. It further stimulated critical employment and skills training in an area grappling with a 52.1% unemployment rate. Work opportunities were unlocked for local community members during the construction period through either direct contracts or through subcontractors. Skills transfers took place through 'on-the-job' training, with the majority of work opportunities filled by local residents, who were a crucial factor in the project's success. Finally, while the initial timeline for the project was adjusted from 36 months to 60 months to accommodate budget planning, GIC's innovative project management approach positioned the development for early completion by as much as a month, demonstrating the company's ability to adapt and the effectiveness of its cutting-edge automated digital project management software. Celebrating the legacy of infrastructure However, GIC Chairman Olebogeng Manhe emphasises the project's broader impact. 'Receiving the Contractor of the Year award serves to recognise the importance of holistic impact, and broad thinking in construction,' he says. 'For example, the hospital will have an enormous effect in positively uplifting and benefitting the surrounding communities. But the training and skills transferred in the construction phase will also live on as part of its legacy, opening the door to new opportunities for youth and community members, and empowering them to participate in future developments, supporting economic development. 'This facility reflects the incredible potential we can unlock by merging construction excellence with meaningful social impact, and by working hand in hand with like-minded and dedicated partners in the public sector who want to join us in changing lives. We are grateful to our public partners in this hospital project for their vision, and look forward to partnering in many new ventures to come.'

‘They are just waiting for me to die': Woman says dept of health reneged on R500k promise
‘They are just waiting for me to die': Woman says dept of health reneged on R500k promise

News24

timea day ago

  • News24

‘They are just waiting for me to die': Woman says dept of health reneged on R500k promise

A 50-year-old Jeffreys Bay woman says severe complications from a 2002 tooth extraction at an Eastern Cape state hospital left her disabled. The Eastern Cape Department of Health offered a R500 000 'humanitarian' payment in 2013, but claims no record shows the offer was accepted. Jantjies protested by sleeping outside the department's provincial headquarters in 2023 and claims her health continues to deteriorate while she survives on a disability grant. A Jeffreys Bay woman has accused the Eastern Cape Department of Health of playing with her emotions over a promised R500 000 'humanitarian' payment for complications she developed after a 2002 tooth extraction. Priscila Tobeka Jantjies, 50, was living in Mdantsane when she went for a tooth extraction at state-owned Cecilia Makiwane Hospital in December 2002. The procedure turned into a nightmare for the mother of two who was admitted to the hospital after losing consciousness. She said she stayed in hospital for days because she was unable to see, walk or speak. When she was discharged, Jantjies claimed her wellbeing was severely affected by the procedure as she was constantly bedridden due to loss of energy. Assisted by her husband, Thomas, and their lawyers, Jantjies launched litigation against the department which was resolved years later through an out-of-court settlement. In a June 2013 letter from the department, addressed to Jantjies and seen by News24, then-acting senior manager of legal services Mlungisi Mlambo wrote that the offer was made 'purely on humanitarian grounds'. Mlambo wrote: The acting superintendent-general [of the department] has reaffirmed that the original offer [is] R500 000 in full and a final settlement offer without admission of liability. The offer was on condition that Thomas accepted it. Thomas died in 2017 and it is unclear if he had accepted it at the time of his death. 'My husband was the one who was signing all the documents on my behalf because I was sick due to complications after the tooth extraction. After he died, I started enquiring about the offer from the department's officials, but they have been sending me from pillar to post,' Jantjies told News24. In March 2023, a frustrated Jantjies went to sleep outside the premises of the department's provincial headquarters in Bhisho in protest against the department's failure to honour the promise. 'I was promised that I would be paid the money with the department's officials saying the money was going to be paid by the end of October 2023. This has not happened,' Jantjies said. She claimed she was also promised, shortly before last year's general elections, that the offer would be paid. 'I have been calling the officials many times without getting anything solid. I guess they are just waiting for me to die. My health has deteriorated,' she said. Jantjies said she was unemployed and was dependent on a disability grant. 'I was never a disabled person until after the tooth extraction.' Department spokesperson Sizwe Kupelo said Jantjies was owed nothing. He admitted there was an offer made for Jantjies, but said the department's records do not show it was accepted. 'There was no basis for that offer. There was no causal nexus for the R500 000. Clinical investigations concluded that her disability was not linked to the tooth extraction and multi-disciplinary government assisted the family and moved them from a shack in [Mdantsane] and built them a house in Jeffreys Bay with furniture,' said Kupelo.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store